Ushering in the Golden Era of Alzheimer Drug Development?

Author(s):

What effect will aducanumab have on Alzheimer disease treatment?

RJ Tesi, MD, discusses the recent aducanumab FDA approval and the implications it will have on the treatment of Alzheimer disease.

Dr Tesi is CEO and Chief Medical Officer of INmuneBio.

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.